5-bromo-1-methyl-1H-indole-3-carbonitrile | 1219741-43-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-bromo-1-methyl-1H-indole-3-carbonitrile
• 英文别名: 5-bromo-1-methylindole-3-carbonitrile
• CAS: 1219741-43-1
• 化学式: C₁₀H₇BrN₂
• 分子量: 235.083
• InChiKey: UWJBLNOJXLOBQD-UHFFFAOYSA-N

物化性质

• 沸点：
  383.1±22.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  28.7
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5-bromo-1-methyl-1H-indole-3-carbonitrile 在 sodium hydrogen sulfide 、 magnesium(II) chloride hexahydrate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 5-bromo-1-methyl-1H-indole-3-carbothioamide
  参考文献：
  名称：

  Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles

  摘要：

  A series of 3,5-bis(indolyl)-1,2,4-thiadiazoles were synthesized and evaluated for their cytotoxicity against selected human cancer cell lines. The reaction of indole-3-thiocarboxamide 3 with iodobenzene diacetate underwent oxidative dimerization to give 3,5-bis(indolyl)-1,2,4-thiadiazoles 4a-n. Among the synthesized bis(indoly)-1,2,4-thiadiazoles, the compound 4h with 4-chlorobenzyl and methoxy substituents showed the most potent activity. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.07.089
• 作为产物：
  描述：

  5-溴吲哚-3-甲醛 在 甲酸 、 盐酸羟胺 、 sodium formate 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 5-bromo-1-methyl-1H-indole-3-carbonitrile
  参考文献：
  名称：

  Synthesis of Novel Indolyl-1,2,4-triazoles as Potent and Selective Anticancer Agents

  摘要：

  A diverse series of 22 indolyl-1,2,4-triazole congeners (6 and 7) have been synthesized from the reaction of indole-3-carbonitrile (4) or (5) with appropriate acid hydrazides in the presence of potassium carbonate. Synthesized compounds were evaluated for their cytotoxicity against six human cancer cell lines, and some of the compounds displayed promising activity. In particular, 3-(3',4',5'-trimethoxyphenyl)-5-(N-methyl-3'-indolyl)-1,2,4-triazole (7i) and 3-(4'-piperidinyl)-5-(N-methyl-3'-indolyl)-1,2,4-triazole (7n) were the most promising and broadly active compounds against the tested cell lines. It was interesting to note that the trimethoxyphenyl analog 7i showed twofold selective cytotoxicity against PaCa2 cell line (IC50 0.8 mu m), whereas piperidinyl analog 7n was found to be selectively cytotoxic against MCF7 cell line (IC50 1.6 mu m). Notably, the 4-fluorophenyl derivative 7c exhibited selective cytotoxicity against PC3 cell line (IC50 4 mu m). The structure-activity relationship study revealed that substituents including 3,4,5-trimethoxyphenyl, 3,4-dimethoxyphenyl, 4-benzyloxy-3-methoxyphenyl, 4-piperidinyl, 4-fluorophenyl and N-methylindole are beneficial for the activity of indolyl-1,2,4-triazoles (6 and 7).

  DOI：

  10.1111/j.1747-0285.2010.01051.x

文献信息

• GaCl₃-Catalyzed C–H Cyanation of Indoles with <i>N</i>-Cyanosuccinimide
  作者：Xue Wang、Mohamed Makha、Shu-Wei Chen、Huaiji Zheng、Yuehui Li

  DOI：10.1021/acs.joc.9b00416

  日期：2019.5.17

  An efficient GaCl3-catalyzed direct cyanation of indoles and pyrroles using bench-stable electrophilic cyanating agent N-cyanosuccinimide was achieved and afforded 3-cyanoindoles and 2-cyanopyrroles in good yields and excellent regioselectivities. Notably, this protocol exhibited high reactivity for unprotected indoles and was applicable to a broad range of indole and pyrrole substrates.

  获得了使用台式稳定的亲电氰化剂N-氰基琥珀酰亚胺有效地GaCl 3催化的吲哚和吡咯直接氰化，并以良好的收率和优异的区域选择性提供了3-氰基吲哚和2-氰基吡咯。值得注意的是，该方案对未保护的吲哚表现出高反应性，并且适用于多种吲哚和吡咯底物。
• Direct C-2 Carboxylation of 3-Substituted Indoles Using a Combined Brønsted Base Consisting of LiO-<i>t</i> Bu/CsF/18-crown-6
  作者：Masanori Shigeno、Itsuki Tohara、Kanako Nozawa-Kumada、Yoshinori Kondo

  DOI：10.1002/ejoc.202000272

  日期：2020.4.7

  A combination of LiO‐tBu, CsF, and 18‐crown‐6 can be used to carboxylate indole derivatives at the C‐2 position under an ambient CO2 atmosphere. Substrates bearing an electrophilic substituent (i.e. CN, formyl, benzoyl, phenylsulfonyl, phenylsulfinyl, and chloride) at the C‐3 position are smoothly converted into their corresponding carboxylated products with high functional group compatibility.

  LiO-的组合吨卜，CsF和18-冠-6可用于羧酸盐的环境CO下在C-2位的吲哚衍生物2的气氛。在C-3位置带有亲电取代基（例如CN，甲酰基，苯甲酰基，苯磺酰基，苯亚磺酰基和氯化物）的底物可以平滑地转化为具有高官能团相容性的相应羧化产物。
• NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS
  申请人：BOOKSER BRETT C.

  公开号：US20100081643A1

  公开（公告）日：2010-04-01

  Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

  结构式（I）的新化合物是AMP-蛋白激酶的激活剂，并且在治疗、预防和抑制由AMPK激活的蛋白激酶介导的疾病方面非常有用。本发明的化合物在治疗2型糖尿病、高血糖、代谢综合征、肥胖、高胆固醇血症和高血压方面非常有用。
• [EN] NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS<br/>[FR] NOUVEAUX DÉRIVÉS DE BENZIMIDAZOLE CYCLIQUES UTILES COMME AGENTS ANTI-DIABÉTIQUES
  申请人：MERCK SHARP & DOHME

  公开号：WO2010047982A1

  公开（公告）日：2010-04-29

  Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, Metabolic Syndrome, obesity, hypercholesterolemia, and hypertension.

  结构式（I）的新化合物是AMP-蛋白激酶的激活剂，并且在治疗、预防和抑制由AMPK激活的蛋白激酶介导的疾病方面非常有用。本发明的化合物在治疗2型糖尿病、高血糖、代谢综合征、肥胖、高胆固醇血症和高血压方面非常有用。
• [EN] NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS<br/>[FR] NOUVEAUX AGENTS ANTIDIABÉTIQUES UTILES AVEC DES DÉRIVÉS DE BENZIMIDAZOLE CYCLIQUES
  申请人：MERCK SHARP & DOHME

  公开号：WO2010051206A1

  公开（公告）日：2010-05-06

  Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK- activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

  结构式（I）的新化合物是AMP-蛋白激酶的激活剂，并且在治疗、预防和抑制由AMPK激活的蛋白激酶介导的疾病方面非常有用。本发明的化合物在治疗2型糖尿病、高血糖、代谢综合征、肥胖、高胆固醇血症和高血压方面非常有用。